• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示和利用人类肠道微生物组在城市化进程中非传染性疾病负担不断增加的过程中的作用。

Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.

机构信息

Key Laboratory of Human Microbiome and Chronic Diseases, Sun Yat-Sen University, Ministry of Education, Guangzhou, China.

Guangdong Institute of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

出版信息

Gut Microbes. 2023 Jan-Dec;15(1):2237645. doi: 10.1080/19490976.2023.2237645.

DOI:10.1080/19490976.2023.2237645
PMID:37498052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10376922/
Abstract

The world is witnessing a global increase in the urban population, particularly in developing Asian and African countries. Concomitantly, the global burden of non-communicable diseases (NCDs) is rising, markedly associated with the changing landscape of lifestyle and environment during urbanization. Accumulating studies have revealed the role of the gut microbiome in regulating the immune and metabolic homeostasis of the host, which potentially bridges external factors to the host (patho-)physiology. In this review, we discuss the rising incidences of NCDs during urbanization and their links to the compositional and functional dysbiosis of the gut microbiome. In particular, we elucidate the effects of urbanization-associated factors (hygiene/pollution, urbanized diet, lifestyles, the use of antibiotics, and early life exposure) on the gut microbiome underlying the pathogenesis of NCDs. We also discuss the potential and feasibility of microbiome-inspired and microbiome-targeted approaches as novel avenues to counteract NCDs, including fecal microbiota transplantation, diet modulation, probiotics, postbiotics, synbiotics, celobiotics, and precision antibiotics.

摘要

世界正见证着全球城市人口的增长,特别是在发展中国家的亚洲和非洲国家。与此同时,非传染性疾病(NCDs)的全球负担正在上升,这与城市化过程中生活方式和环境的变化明显相关。越来越多的研究揭示了肠道微生物组在调节宿主免疫和代谢平衡中的作用,这可能将外部因素与宿主(病理)生理学联系起来。在这篇综述中,我们讨论了城市化过程中 NCDs 发病率的上升及其与肠道微生物组组成和功能失调的关系。特别是,我们阐明了城市化相关因素(卫生/污染、城市化饮食、生活方式、抗生素的使用和早期生活暴露)对 NCDs 发病机制下肠道微生物组的影响。我们还讨论了基于微生物组的方法和针对微生物组的方法作为对抗 NCDs 的新途径的潜力和可行性,包括粪便微生物群移植、饮食调节、益生菌、后生元、合生菌、纤维素和精准抗生素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/215767eeb96d/KGMI_A_2237645_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/af6ef4f4c83a/KGMI_A_2237645_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/1eb109ee80c0/KGMI_A_2237645_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/82d8b63a6e31/KGMI_A_2237645_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/215767eeb96d/KGMI_A_2237645_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/af6ef4f4c83a/KGMI_A_2237645_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/1eb109ee80c0/KGMI_A_2237645_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/82d8b63a6e31/KGMI_A_2237645_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc8/10376922/215767eeb96d/KGMI_A_2237645_F0004_OC.jpg

相似文献

1
Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.揭示和利用人类肠道微生物组在城市化进程中非传染性疾病负担不断增加的过程中的作用。
Gut Microbes. 2023 Jan-Dec;15(1):2237645. doi: 10.1080/19490976.2023.2237645.
2
Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.针对肠道微生物群治疗多种疾病的不同策略:一种可持续的方法。
Infect Disord Drug Targets. 2024;24(5):e160124225675. doi: 10.2174/0118715265267536231121095634.
3
Gut microbiome-targeted therapies for Alzheimer's disease.针对阿尔茨海默病的肠道微生物组靶向治疗。
Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.
4
Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?老年人群肠道菌群失调及相关疾病的治疗干预:抗生素、益生菌还是粪便微生物移植?
Benef Microbes. 2017 Apr 26;8(2):179-192. doi: 10.3920/BM2016.0115. Epub 2016 Dec 23.
5
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
6
Microbiomes in physiology: insights into 21st-century global medical challenges.生理微生物组学:探索 21 世纪全球医疗挑战。
Exp Physiol. 2022 Apr;107(4):257-264. doi: 10.1113/EP090226. Epub 2022 Feb 14.
7
Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases.肠道微生物组成对慢性非传染性疾病的发生和发展的影响。
Nutrients. 2019 May 14;11(5):1073. doi: 10.3390/nu11051073.
8
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.肠道微生物群在预防和治疗脓毒症中的治疗潜力。
Front Immunol. 2018 Sep 10;9:2042. doi: 10.3389/fimmu.2018.02042. eCollection 2018.
9
Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.神经性厌食症与肠道微生物群:对体重变化及新疗法的影响
Expert Rev Gastroenterol Hepatol. 2022 Apr;16(4):321-332. doi: 10.1080/17474124.2022.2056017. Epub 2022 Mar 22.
10
Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.饮食、肠道微生物群与肥胖:与宿主遗传学和表观遗传学的关联及其潜在应用。
Adv Nutr. 2019 Jan 1;10(suppl_1):S17-S30. doi: 10.1093/advances/nmy078.

引用本文的文献

1
Double-Edged Sword: Urbanization and Response of Amniote Gut Microbiome in the Anthropocene.双刃剑:人类世中的城市化与羊膜动物肠道微生物组的响应
Microorganisms. 2025 Jul 25;13(8):1736. doi: 10.3390/microorganisms13081736.
2
The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications.胃肠道疾病及其他情况下与细菌群落相关的肠道病毒组:作用、机制及临床应用
Precis Clin Med. 2025 May 28;8(2):pbaf010. doi: 10.1093/pcmedi/pbaf010. eCollection 2025 Jun.
3
Insights on the Health Benefits and Functional Potential of Food Bioactive Compounds.

本文引用的文献

1
First oral fecal microbiota transplant therapy approved.首例口服粪菌移植疗法获批。
Nat Med. 2023 Jul;29(7):1581-1582. doi: 10.1038/d41591-023-00046-2.
2
The role of faecal microbiota transplantation in chronic noncommunicable disorders.粪便微生物群移植在慢性非传染性疾病中的作用。
J Autoimmun. 2023 Dec;141:103034. doi: 10.1016/j.jaut.2023.103034. Epub 2023 Apr 20.
3
Effects of Fermented Food Consumption on Non-Communicable Diseases.食用发酵食品对非传染性疾病的影响。
食品生物活性化合物的健康益处及功能潜力洞察
Foods. 2025 Jun 4;14(11):1984. doi: 10.3390/foods14111984.
4
Global Research Trends and Hotspots in the Role of Cholesterol in Colorectal Cancer: A Bibliometric Analysis.胆固醇在结直肠癌中作用的全球研究趋势与热点:一项文献计量分析
Hum Mutat. 2025 May 24;2025:6546114. doi: 10.1155/humu/6546114. eCollection 2025.
5
Immune-mediated disease caused by climate change-associated environmental hazards: mitigation and adaptation.气候变化相关环境危害导致的免疫介导疾病:缓解与适应
Front Sci. 2024;2. doi: 10.3389/fsci.2024.1279192. Epub 2024 Apr 3.
6
Thiamine, gastrointestinal beriberi and acetylcholine signaling.硫胺素、胃肠道脚气病与乙酰胆碱信号传导
Front Nutr. 2025 Apr 9;12:1541054. doi: 10.3389/fnut.2025.1541054. eCollection 2025.
7
Human microbiome acquisition and transmission.人类微生物组的获得与传播。
Nat Rev Microbiol. 2025 Mar 21. doi: 10.1038/s41579-025-01166-x.
8
Rurality and relative poverty drive acquisition of a stable and diverse gut microbiome in early childhood in a non-industrialized setting.在非工业化环境中,农村地区和相对贫困促使幼儿期获得稳定且多样的肠道微生物群。
Sci Rep. 2025 Feb 15;15(1):5601. doi: 10.1038/s41598-025-89224-5.
9
A Comprehensive Review on Deep Eutectic Solvents: Their Current Status and Potential for Extracting Active Compounds from Adaptogenic Plants.深共熔溶剂:从适应原植物中提取活性化合物的现状及潜力的全面综述。
Molecules. 2024 Oct 9;29(19):4767. doi: 10.3390/molecules29194767.
10
Importance of diet and intestinal microbiota in the prevention of colorectal cancer - colonoscopy early screening diagnosis.饮食和肠道微生物群在预防结直肠癌——结肠镜早期筛查诊断中的重要性。
World J Gastrointest Oncol. 2024 Aug 15;16(8):3428-3435. doi: 10.4251/wjgo.v16.i8.3428.
Foods. 2023 Feb 4;12(4):687. doi: 10.3390/foods12040687.
4
Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.帕金森病中的信号通路:分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Feb 21;8(1):73. doi: 10.1038/s41392-023-01353-3.
5
Acetyltransferase from blunts colorectal tumourigenesis by reprogramming tumour microenvironment.乙酰基转移酶通过重塑肿瘤微环境来减缓结直肠肿瘤的发生。
Gut. 2023 Jul;72(7):1308-1318. doi: 10.1136/gutjnl-2022-327853. Epub 2023 Feb 8.
6
T17 cell heterogeneity and its role in tissue inflammation.T17 细胞异质性及其在组织炎症中的作用。
Nat Immunol. 2023 Jan;24(1):19-29. doi: 10.1038/s41590-022-01387-9. Epub 2023 Jan 3.
7
Microbiome-based interventions to modulate gut ecology and the immune system.基于微生物组的干预措施来调节肠道生态和免疫系统。
Mucosal Immunol. 2022 Jun;15(6):1095-1113. doi: 10.1038/s41385-022-00564-1. Epub 2022 Sep 30.
8
Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial.短链脂肪酸是地中海饮食对肠道屏障完整性的有利影响的关键介质:来自随机对照 LIBRE 试验的数据。
Am J Clin Nutr. 2022 Oct 6;116(4):928-942. doi: 10.1093/ajcn/nqac175.
9
Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance.非营养性甜味剂对人体葡萄糖耐量的个性化微生物群驱动效应。
Cell. 2022 Sep 1;185(18):3307-3328.e19. doi: 10.1016/j.cell.2022.07.016. Epub 2022 Aug 19.
10
Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.粪便微生物群移植与糖皮质激素治疗轻中度溃疡性结肠炎诱导缓解的比较。
J Transl Med. 2022 Aug 12;20(1):354. doi: 10.1186/s12967-022-03569-3.